Beyond Anthrax: The Weaponization of Infectious Diseases

Larry I. Lutwick (Ed.)

ISBN 10: 1588294382 / ISBN 13: 9781588294388

Published by Humana Press Inc., 2008

About this Item

Beyond Anthrax: The Weaponization of Infection covers the gamut of potential biowarfare/bioterrorism threats as well as significant issues related to classical and new epidemics. Various aspects of the public health response to infections are also covered. Editor(s): Lutwick, Larry I.; Lutwick, Suzanne M. BIC Classification: MJCJ. Dimension: 235 x 155. Weight in Grams: 748. . 2008. 2009th Edition. Hardcover. . . . . Books ship from the US and Ireland.

Seller Inventory # V9781588294388

Bibliographic Details

• Title: Beyond Anthrax: The Weaponization of Infectious Diseases
• Publisher: Humana Press Inc.
• Publication Date: 2008
• Language: English
• ISBN 10: 1588294382
• ISBN 13: 9781588294388
• Binding: Hardcover
• Condition: New

About this title

Synopsis

Biological warfare has, unfortunately, in the post 9/11 world become a significant topic of discussion in both the medical and lay presses. In the wake of the biological "letter bombs" containing anthrax spores, the possibility of biologic and/or toxic attacks on civilians in any part of the world became no longer a possibility. It is now part of common discussion and consciousness.

This book presents the history of the topics and clinically relevant discussions on those high risk (Category A) diseases beyond anthrax as well as a number of infections and toxins at the Category B level. Importantly, in addition, the text includes sections on Public Health Infrastructure, Public Health Law, Surveillance, Mental Health Management and Media Role all of which relate to epidemics of any sort, not just intentional biological events.

Beyond Anthrax: The Weaponization of Infectious Diseases is a product that should serve as a reference point for clinicians, epidemiologists and public health personnel to understand in practical detail many of the aspects of weapons of biowarfare as well as the appropriate responses to them.

About the Author

Larry I. Lutwick, MD is Director of the Infectious Disease Unit at the Brooklyn Campus of the Veterans Affairs New York Harbor Health Care System in Brooklyn, New York and Professor of Medicine at the State University of New York, Downstate Medical Center.

Suzanne M. Lutwick, MPH is Director of Grant Development for the Hackensack University Medical Center Foundation in Hackensack, New Jersey and adjunct faculty at State University of New York, Downstate Medical Center and at Seton Hall University, East Orange, New Jersey.